Asian populations with atrial fibrillation benefit from better stroke prevention with Pradaxa® compared to warfarin
New findings presented at the 2nd Asia Pacific Stroke Conference...
12 September 2012 | By Boehringer Ingelheim
New findings presented at the 2nd Asia Pacific Stroke Conference...